Transplantation of organs from animals to humans could soon be a reality

Scientists now believe the transplantation of organs from animals to humans could soon be a reality.

Speaking at the BA Festival of Science in Dublin, Dr Anthony Warrens, discussed how xenotransplantation, the process of transplanting organs from one species into another, could soon be a reality, easing the current shortage of organs for transplantation.

Dr Anthony Warrens, from Imperial College London and Hammersmith Hospital, says: "Although the idea of xenotransplantation is far from new, it is only in recent years that many of the potential immunological problems, such as transplant rejection, have been solved, meaning the process of transplanting organs from one species into another, could soon be a reality."

"With the increasing shortage of donors for organ transplants, the use of animal organs may be the only hope for many suffering from problems such as kidney, heart or lung failure."

Despite the progress made in this field there are still a number of problems associated with transplanting animal organs into humans. The dangers of animal viruses crossing over and infecting humans are still a cause for concern, as researchers have been unable to create an animal model to test the likelihood and extent of any cross over.

In addition, unknown animal pathogens could prove a potential problem.

While scientists can create treatment and transplant rejection prevention strategies for known human pathogens, they are unable to do so for animal pathogens, whose effects on humans may not be fully known.

Dr Warrens adds: "Despite the risks, xenotransplantation may be the best hope we have for dealing with the current transplant shortage. Currently there are around 6000 on the kidney transplant waiting list, whose condition will only get worse without a transplant. Although we can't say there is absolutely no danger of cross infection, I believe that in the future we will be able to deal with many of the problems, reducing any potential risk."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Trial finds no benefit of adding nivolumab to tivozanib for advanced kidney cancer